Biotech Earnings: Tenax, ADC, and Rapport Report FY 2025 Results
Tenax Therapeutics, ADC Therapeutics, and Rapport Therapeutics released their full-year 2025 financial results, highlighting critical pipeline milestones and cash runway extensions. The reports underscore a pivotal shift toward Phase 3 data readouts and commercial scaling in the specialized biotech sector.